These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 16009596
1. HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece. Rigopoulou EI, Stefanidis I, Liaskos C, Zervou EK, Rizos C, Mina P, Zachou K, Syrganis C, Patsidis E, Kyriakopoulos G, Sdrakas L, Tsianas N, Dalekos GN. J Clin Virol; 2005 Sep; 34(1):81-5. PubMed ID: 16009596 [Abstract] [Full Text] [Related]
2. Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center. Khan N, Aswad S, Shidban H, Aghajani M, Mendez R, Mendez R, Comanor L. J Clin Virol; 2004 Jun; 30(2):175-82. PubMed ID: 15125874 [Abstract] [Full Text] [Related]
3. Hepatitis C infection in dialysis patients in Israel. Weinstein T, Tur-Kaspa R, Chagnac A, Korzets A, Ori Y, Zevin D, Herman M, Gafter U. Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373 [Abstract] [Full Text] [Related]
4. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H. Ren Fail; 2006 Mar; 28(8):729-35. PubMed ID: 17162434 [Abstract] [Full Text] [Related]
5. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study. Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Di Filippo S, Erba G, Pagano A, Locatelli F. Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533 [Abstract] [Full Text] [Related]
6. Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue. Hofmann WP, Dries V, Herrmann E, Gärtner B, Zeuzem S, Sarrazin C. J Clin Virol; 2005 Apr; 32(4):289-93. PubMed ID: 15780807 [Abstract] [Full Text] [Related]
7. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution]. Bozdayi G, Rota S, Verdi H, Derici U, Sindel S, Bali M, Başay T. Mikrobiyol Bul; 2002 Apr; 36(3-4):291-300. PubMed ID: 12838663 [Abstract] [Full Text] [Related]
8. HBV-DNA in hemodialysis patients infected by HCV. Arababadi MK, Hassanshahi G, Yousefi H. Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941 [Abstract] [Full Text] [Related]
9. [Distribution of hepatitis C virus genotypes among the hemodialysis population in the province of Alicante]. Arenas MD, Muñoz C, Sánchez-Payá J, Jover R, Egea JJ, Gil MT, Martín F, Sarró F, Soriano A, Luna A, Olivares J, Reyes A, Muñoz del Bustillo E, del Pozo C, Valverde V, Perdiguero M, Araque A. Nefrologia; 2001 May; 21(6):581-7. PubMed ID: 11881428 [Abstract] [Full Text] [Related]
10. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, Alavian SM. J Med Virol; 2006 May; 78(5):569-73. PubMed ID: 16555284 [Abstract] [Full Text] [Related]
11. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis. Lemos LB, Perez RM, Matos CA, Silva IS, Silva AE, Ferraz ML. J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594 [Abstract] [Full Text] [Related]
12. [Examination of HCV infection in hemodialysis patients with HCV-RNA assay using a magnetic extraction method (AmpliCap GT HCV MONITOR Test Kit v2.0 and AmpliCap GT HCV Specimen Preparation Kit v2.0)]. Tanaka M, Fujiyama S, Tanaka M, Itoh K, Matsushita K, Hara M, Kuwahara K, Yasumoto N, Nishimura Y, Yoshimura N, Tomita K. Nihon Jinzo Gakkai Shi; 2003 Feb; 45(2):91-7. PubMed ID: 12703404 [Abstract] [Full Text] [Related]
13. [Hepatitis C virus infection in hemodialysis patients]. Li JS. Zhonghua Yi Xue Za Zhi; 1992 Nov; 72(11):655-7, 701. PubMed ID: 1284485 [Abstract] [Full Text] [Related]
14. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, Amini A, Rahim Rezaee SA. Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521 [Abstract] [Full Text] [Related]
15. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients. Medhi S, Potukuchi SK, Polipalli SK, Swargiary SS, Deka P, Chaudhary A, Begum N, Hussain Z, Ahlawat RS, Kar P. Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117 [Abstract] [Full Text] [Related]
16. Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi-Arabia. Bosmans JL, Nouwen EJ, Behets G, Gorteman K, Huraib SO, Shaheen FA, Maertens G, Verpooten GA, Elseviers MM, de Broe ME. Clin Nephrol; 1997 Apr; 47(4):256-62. PubMed ID: 9128793 [Abstract] [Full Text] [Related]
17. Transcription-mediated amplification (TMA) for the assessment of viremia in hemodialysis patients with hepatitis C. Bastos DO, Perez RM, Silva IS, Lemos LB, Simonetti JP, Medina-Pestana JO, Silva AE, Ferraz ML. J Med Virol; 2012 Apr; 84(4):596-600. PubMed ID: 22337298 [Abstract] [Full Text] [Related]
18. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. Lopes EP, Gouveia EC, Albuquerque AC, Sette LH, Mello LA, Moreira RC, Coelho MR. J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052 [Abstract] [Full Text] [Related]
19. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. Bouzgarrou N, Fodha I, Othman SB, Achour A, Grattard F, Trabelsi A, Pozzetto B. J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976 [Abstract] [Full Text] [Related]
20. Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. Comanor L, Anderson F, Ghany M, Perrillo R, Heathcote EJ, Sherlock C, Zitron I, Hendricks D, Gordon SC. Am J Gastroenterol; 2001 Oct; 96(10):2968-72. PubMed ID: 11693334 [Abstract] [Full Text] [Related] Page: [Next] [New Search]